A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
Ribosomal RNA (rRNA), made from many copies of ribosomal DNA (rDNA), is the core component that powers ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Airborne genetic material can be used to paint a picture of ecosystem health, watch for invasive species and even identify ...
The genome has thousands of genes that code for proteins, which help carry out many of the cell's important functions. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results